Plus Therapeutics, Inc. Gains 57.64%

Plus Therapeutics, Inc. (PSTV:NASDAQ) rocketted at $2.27, representing a gain of 57.6%. The stock got featured on our News Catalysts scanner on Mon 30 Mar 20 at 04:25 PM in the 'EARNINGS' category.

About Plus Therapeutics, Inc. (PSTV:NASDAQ)

Cytori Therapeutics Inc is a specialty therapeutics company. It focuses to provide meaningful and quality therapeutic options with a broad utility that benefit patients and healthcare providers. The company has two therapeutic development platforms: Cytori Cell Therapy (CCT) and Cytori Nanomedicine. The CCT platform is based on the scientific discovery that the human adipose or fat tissue compartment is a source of a mixed population of stem, progenitor and regenerative cells. The Cytori Nanomedicine Platform features a versatile and novel protein-stabilized liposomal nanoparticle technology for drug encapsulation that provides the foundation to bring two drugs into early/ late-stage clinical trials.